RE:RE:RE:With the spotlight and focus off NovoLove the a*shole who called me a "newbie" on Thursday night on NVO board, after I said watch-out, and then Novo hit by another 11 % drop.
Total destruction to NVO shareholders. Completely pre-revenue all blue sky. I still can't believe it traded over $ 1.3 B. Let's see them bulk sample a bunch of powder. They will burn through cash like crazy. More dilution inevitable.
This was Sprott's fantasy by pushing his BoD to plunge the $ 56 M USD into Novo in September. All about a personal agenda with NVO and GGI and pure promotion. I am thinking now back to the Timminco story although that was far far worse.
First bad move KL has done all year. That could have gone to dividends and rewarding shareholders plain and simple.
Meanwhile poor KLDX is barely over $ 450 M USD market cap. The market has destroyed us. My MUX shares have come back up very nicely all week.
So have many other midtiers but KLDX just can't seem to break and hold $ 2.55 USD.
There has been no real recovery in the KLDX share price unlike many other midtiers that have re-captured lots of the downside the past 2,5 weeks. I think the market is really truly waiting on guidance for 2018 as well as Q4 production #s. Best value I see now in the small midtier space going into 2018.
JIN
goldminer01 wrote: Good point, maybe they even consider HQ move to Reno and even could sell TN for $80M cash to SSRM.
Reverse the GAAP plunge entirely.
BTW - U.S. GAAP will be helpful in 2018 as many of the start-up costs needed to be expensed
across low 2P. The reserves will grow in next issuance Q1, the spending in 2018 I would imagine will be much lower than 2017 as a percent of revenue. EPS then becomes a factor again that can be tracked, and U.S. taxes of only 21 % vs. 35 % will be very meaningful to cashflow.
They should sell at 6-7X cashlfow in 2018, today around 3-4X. A synergistic takeover at 10X is not too pricey.